Literature DB >> 26890663

Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.

Andrew N Siedlecki1, Stephanie Tapp, Anna N A Tosteson, Robin J Larson, Carol L Karp, Thomas Lietman, Michael E Zegans.   

Abstract

PURPOSE: To compare treatment strategies for ocular surface squamous neoplasia (OSSN), ranging from surgical excision to empiric topical interferon alpha-2b (IFN-α2b).
METHODS: A decision model was constructed to determine which of 4 treatment strategies minimized expected persistence/recurrence of disease in patients with OSSN: excision followed by repeat excision for positive surgical margins, excision followed by IFN-α2b for positive margins, incisional biopsy followed by IFN-α2b for positive biopsies, and empiric treatment with IFN-α2b. Probabilities were estimated from literature published between 1983 and 2015. Expected values for the probability of recurrence could range from 0 (no persistence/recurrence) to 1 (persistence/recurrence). Sensitivity analyses were performed for each variable.
RESULTS: Excision followed by IFN-α2b for positive margins was estimated to minimize persistence/recurrence of OSSN (expected value 0.13 versus 0.17 for empiric IFN-α2b, 0.22 for excision-only, and 0.30 for incisional biopsy-directed IFN-α2b). The optimal strategy was sensitive to 3 variables: efficacy of IFN-α2b, recurrence after negative surgical margins, and accuracy of excisional biopsy.
CONCLUSIONS: In our decision analysis using studies published between 1983 and 2015, surgical excision followed by IFN-α2b for positive margins is the favored strategy for minimizing persistence/recurrence of OSSN. Future prospective studies would add to the certainty of these conclusions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26890663      PMCID: PMC5628393          DOI: 10.1097/ICO.0000000000000766

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  50 in total

1.  Reliability of impression cytology for the diagnosis of ocular surface squamous neoplasia employing the Biopore membrane.

Authors:  D M Tole; P A McKelvie; M Daniell
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

2.  Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.

Authors:  S Esquenazi; C L Fry; E Holley
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Epidemiology of squamous cell conjunctival cancer.

Authors:  E C Sun; T R Fears; J J Goedert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-02       Impact factor: 4.254

4.  Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases.

Authors:  M Tunc; D H Char; B Crawford; T Miller
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

5.  Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain reaction.

Authors:  Y Nakamura; Y Mashima; K Kameyama; M Mukai; Y Oguchi
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

Review 6.  Ocular surface squamous neoplasia.

Authors:  G A Lee; L W Hirst
Journal:  Surv Ophthalmol       Date:  1995 May-Jun       Impact factor: 6.048

7.  Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.

Authors:  Carol L Karp; Anat Galor; Sachin Chhabra; Scott D Barnes; Eduardo C Alfonso
Journal:  Ophthalmology       Date:  2010-12       Impact factor: 12.079

8.  Ocular surface squamous neoplasia (squamous cell carcinoma) of the socket: management of extensive tumors with interferon.

Authors:  Carol L Shields; Swarupa Kancherla; Carlos G Bianciotto; Sara E Lally; Jerry A Shields
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2011 Jul-Aug       Impact factor: 1.746

9.  Risk factors for conjunctival squamous cell neoplasia: a matched case-control study.

Authors:  W Tulvatana; P Bhattarakosol; L Sansopha; W Sipiyarak; E Kowitdamrong; T Paisuntornsug; S Karnsawai
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 10.  Epidemiology of ocular surface squamous neoplasia in Africa.

Authors:  Stephen Gichuhi; Mandeep S Sagoo; Helen A Weiss; Matthew J Burton
Journal:  Trop Med Int Health       Date:  2013-10-30       Impact factor: 2.622

View more
  12 in total

1.  Surgical versus medical treatment for ocular surface squamous neoplasia: A quality of life comparison.

Authors:  Carolina L Mercado; Cameron Pole; James Wong; Juan F Batlle; Fabiola Roque; Noah Shaikh; Juan C Murillo; Anat Galor; Carol L Karp
Journal:  Ocul Surf       Date:  2018-09-11       Impact factor: 5.033

2.  [Conjunctival malignancies].

Authors:  Claudia Auw-Hädrich; Thomas Reinhard
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

3.  Dacryoendoscopy-guided transcanalicular intralesional interferon alpha 2b for canalicular squamous papillomas.

Authors:  Mohammad Javed Ali; Swati Singh; Anasua Ganguly; Milind N Naik
Journal:  Int Ophthalmol       Date:  2017-05-24       Impact factor: 2.031

4.  Update on the Management of Ocular Surface Squamous Neoplasia.

Authors:  Umangi Patel; Carol L Karp; Sander R Dubovy
Journal:  Curr Ophthalmol Rep       Date:  2021-02-20

5.  A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom.

Authors:  Christine A Kiire; Rosalind M K Stewart; Sathish Srinivasan; Heinrich Heimann; Stephen B Kaye; Baljean Dhillon
Journal:  Eye (Lond)       Date:  2018-12-28       Impact factor: 3.775

Review 6.  Update on pharmacotherapy for ocular surface squamous neoplasia.

Authors:  Ghada Al Bayyat; Dan Arreaza-Kaufman; Nandini Venkateswaran; Anat Galor; Carol L Karp
Journal:  Eye Vis (Lond)       Date:  2019-08-12

7.  Management Issues in Conjunctival Tumours: Ocular Surface Squamous Neoplasia.

Authors:  Victoria M L Cohen; Roderick F O'Day
Journal:  Ophthalmol Ther       Date:  2019-11-23

8.  Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.

Authors:  Raffaele Parrozzani; Luisa Frizziero; Sara Trainiti; Ilaria Testi; Giacomo Miglionico; Elisabetta Pilotto; Stella Blandamura; Ambrogio Fassina; Edoardo Midena
Journal:  Br J Ophthalmol       Date:  2016-12-09       Impact factor: 4.638

Review 9.  Ocular surface squamous neoplasia in HIV-infected patients: current perspectives.

Authors:  Shweta Gupta Rathi; Anasua Ganguly Kapoor; Swathi Kaliki
Journal:  HIV AIDS (Auckl)       Date:  2018-03-14

Review 10.  Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.

Authors:  Maria Vittoria Cicinelli; Alessandro Marchese; Francesco Bandello; Giulio Modorati
Journal:  Ophthalmol Ther       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.